Erik C. Hett
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
Papers in
-
- Protein Degradation and Inhibitors 3
- Chemical Synthesis and Analysis 2
-
- Tuberculosis Research and Epidemiology 5
- Co-authors
- Eric J. Rubin (6 shared papers)Michael C. Chao (3 shared papers)Lyn H. Jones (9 shared papers)Lingyi Deng (3 shared papers)Olugbeminiyi Fadeyi (6 shared papers)Scott L. O’Neill (1 shared paper)John S. Brownstein (1 shared paper)Arjun Narayanan (3 shared papers)
- Journals
- ACS Chemical Biology (4 papers)Nature Chemical Biology (3 papers)Journal of Translational Medicine (2 papers)PLoS Pathogens (2 papers)Molecular BioSystems (2 papers)
- Partner nations
- United StatesRussiaChina
In The Last Decade
Erik C. Hett
32 papers receiving 2.1k citations
Erik C. Hett's Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Medicine 164
- Infectious Diseases 494
- Organic Chemistry 668
- Molecular Biology 1.1k
- Pharmaceutical Science 94
Countries citing papers authored by Erik C. Hett
This map shows the geographic impact of Erik C. Hett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik C. Hett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik C. Hett more than expected).
Fields of papers citing papers by Erik C. Hett
This network shows the impact of papers produced by Erik C. Hett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik C. Hett. The network helps show where Erik C. Hett may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik C. Hett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 290 | |
| 2 | Microenvironment mapping via Dexter energy transfer on immune cells Hit paper breakdown → | 2020 | 267 |
| 3 | 2014 | 265 | |
| 4 | 2015 | 161 | |
| 5 | 2008 | 130 | |
| 6 | 2007 | 121 | |
| 7 | 2003 | 113 | |
| 8 | 2017 | 107 | |
| 9 | 2010 | 96 | |
| 10 | Immunogenic cell death in cancer: concept and therapeutic implications Hit paper breakdown → | 2023 | 94 |
| 11 | 2008 | 74 | |
| 12 | 2015 | 72 | |
| 13 | 2013 | 68 | |
| 14 | 2014 | 67 | |
| 15 | 2020 | 46 | |
| 16 | 2022 | 38 | |
| 17 | 2017 | 24 | |
| 18 | 2002 | 19 | |
| 19 | 2013 | 17 | |
| 20 | 2016 | 16 |
About Erik C. Hett
Erik C. Hett is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Epidemiology and Molecular Medicine, having authored 32 papers that have together received 2.2k indexed citations. Recurring topics across this work include Click Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Tuberculosis Research and Epidemiology (5 papers), Antibiotic Resistance in Bacteria (5 papers), Mycobacterium research and diagnosis (4 papers), Protein Degradation and Inhibitors (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Molecular Medicine (164 citations), Infectious Diseases (494 citations), Organic Chemistry (668 citations), Molecular Biology (1.1k citations) and Pharmaceutical Science (94 citations). Erik C. Hett has collaborated with scholars based in United States, Russia and China. Frequent co-authors include Eric J. Rubin, Michael C. Chao, Lyn H. Jones, Lingyi Deng, Olugbeminiyi Fadeyi, Scott L. O’Neill, John S. Brownstein, Arjun Narayanan, A. Gilbert and Lee R. Roberts. Their work appears in journals such as ACS Chemical Biology, Nature Chemical Biology, Journal of Translational Medicine, PLoS Pathogens and Molecular BioSystems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.